[go: up one dir, main page]

SG11201401579UA - Hpv chimaeric particle - Google Patents

Hpv chimaeric particle

Info

Publication number
SG11201401579UA
SG11201401579UA SG11201401579UA SG11201401579UA SG11201401579UA SG 11201401579U A SG11201401579U A SG 11201401579UA SG 11201401579U A SG11201401579U A SG 11201401579UA SG 11201401579U A SG11201401579U A SG 11201401579UA SG 11201401579U A SG11201401579U A SG 11201401579UA
Authority
SG
Singapore
Prior art keywords
chimaeric
hpv
particle
hpv chimaeric
chimaeric particle
Prior art date
Application number
SG11201401579UA
Inventor
Edward Peter Rybicki
Inga Isabel Hitzeroth
Original Assignee
Univ Cape Town
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cape Town filed Critical Univ Cape Town
Publication of SG11201401579UA publication Critical patent/SG11201401579UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01DNA viruses
    • C07K14/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • C12N7/045Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201401579UA 2011-12-01 2012-12-03 Hpv chimaeric particle SG11201401579UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201108841 2011-12-01
PCT/IB2012/056912 WO2013080187A1 (en) 2011-12-01 2012-12-03 Hpv chimaeric particle

Publications (1)

Publication Number Publication Date
SG11201401579UA true SG11201401579UA (en) 2014-07-30

Family

ID=48534756

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401579UA SG11201401579UA (en) 2011-12-01 2012-12-03 Hpv chimaeric particle

Country Status (18)

Country Link
US (1) US9771397B2 (en)
EP (1) EP2785842A4 (en)
JP (1) JP6228922B2 (en)
KR (1) KR102013801B1 (en)
CN (1) CN103890177B (en)
AU (1) AU2012345443B2 (en)
BR (1) BR112014012491A2 (en)
CA (1) CA2850293C (en)
HK (1) HK1198703A1 (en)
IL (1) IL232584B (en)
IN (1) IN2014DN03054A (en)
MX (1) MX355352B (en)
MY (1) MY184076A (en)
PH (1) PH12014500466A1 (en)
RU (1) RU2642287C2 (en)
SG (1) SG11201401579UA (en)
WO (1) WO2013080187A1 (en)
ZA (1) ZA201403557B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3427755B1 (en) 2009-04-13 2020-10-21 INSERM - Institut National de la Santé et de la Recherche Médicale Hpv particles and uses thereof
US9700639B2 (en) 2012-02-07 2017-07-11 Aura Biosciences, Inc. Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
JP6444417B2 (en) 2013-09-18 2018-12-26 オーラ バイオサイエンシーズ, インコーポレイテッド Virus-like particle conjugates for diagnosing and treating tumors
CN104531741B (en) * 2014-08-22 2016-08-24 天津康希诺生物技术有限公司 Strengthen the immunogenic method of HPV epitope peptide and viruslike particle, preparation method of granules and application
CN105801704B (en) * 2014-12-31 2020-06-02 艾托金生物医药(苏州)有限公司 Construction method and application of recombinant vaccine with anti-cervical cancer cell activity
AU2016308290B2 (en) 2015-08-18 2022-04-14 Rakuten Medical, Inc. Compositions, combinations and related methods for photoimmunotherapy
AU2016308286B2 (en) 2015-08-18 2022-04-07 Rakuten Medical, Inc. Phthalocyanine dye conjugates and their storage
CA3003728A1 (en) 2015-10-30 2017-05-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Targeted cancer therapy
WO2018187515A1 (en) 2017-04-04 2018-10-11 Avidea Technologies, Inc. Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
BR112019027488A2 (en) 2017-06-23 2020-07-07 Pathovax Llc chimeric virus-like particles and uses of these as redirectors of antigen-specific immune responses
US11560408B2 (en) 2018-12-27 2023-01-24 Verimmune Inc. Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
PL4001298T3 (en) 2019-07-19 2025-06-16 Sinocelltech Ltd Polyvalent immunogenicity composition for human papillomavirus
WO2021161179A1 (en) * 2020-02-10 2021-08-19 University Of Cape Town Plant produced bovine papillomavirus virus-like particles and pseudovirions
MX2023004465A (en) 2020-10-19 2023-06-19 Verimmune Inc Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer.
KR102821363B1 (en) 2023-02-06 2025-06-13 영산대학교산학협력단 A bathymetry system based on a lidar sensor mounted on a drone

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0757717T3 (en) * 1994-05-16 2006-09-25 Merck & Co Inc papillomavirus vaccines
SI1105466T1 (en) 1998-08-14 2006-08-31 Merck & Co Inc Process for purifying human papillomavirus virus-like particles
US20020016372A1 (en) * 2000-07-31 2002-02-07 Allison Anthony Clifford Method for preventing and treating alzheimer's disease and brain damage associated with cardiov ascular disease and head injury
WO2003068993A1 (en) 2002-02-14 2003-08-21 Novavax, Inc. Method for isolation and purification of expressed gene products in vitro
US7407807B2 (en) * 2002-05-17 2008-08-05 University Of Cape Town Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles
ES2662118T3 (en) 2005-04-29 2018-04-05 University Of Cape Town Expression of viral proteins in plants
CN107080833A (en) * 2009-04-10 2017-08-22 约翰·霍普金斯大学 It is used as wide spectrum HPV(HPV)The papillomavirus sample particle of vaccine(VLP)
CN102215861B (en) 2009-06-19 2014-10-08 艾金株式会社 Vaccine for cervical cancer
AU2010264695A1 (en) * 2009-06-25 2012-01-19 Glaxosmithkline Biologicals S.A. Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease
WO2011077371A1 (en) * 2009-12-22 2011-06-30 University Of Cape Town Method for enhancing the expression of hpv l1

Also Published As

Publication number Publication date
RU2642287C2 (en) 2018-01-24
CA2850293A1 (en) 2013-06-06
AU2012345443A1 (en) 2014-04-17
IL232584B (en) 2018-10-31
KR102013801B1 (en) 2019-08-23
NZ622595A (en) 2016-04-29
CN103890177A (en) 2014-06-25
US9771397B2 (en) 2017-09-26
JP6228922B2 (en) 2017-11-08
HK1198703A1 (en) 2015-05-29
MX355352B (en) 2018-04-17
IL232584A0 (en) 2014-06-30
PH12014500466A1 (en) 2022-05-11
US20140377367A1 (en) 2014-12-25
KR20140098061A (en) 2014-08-07
AU2012345443B2 (en) 2017-10-26
CN103890177B (en) 2016-03-09
RU2014126587A (en) 2016-01-27
ZA201403557B (en) 2020-10-28
EP2785842A4 (en) 2015-11-25
EP2785842A1 (en) 2014-10-08
IN2014DN03054A (en) 2015-05-15
WO2013080187A1 (en) 2013-06-06
MX2014006520A (en) 2014-11-21
CA2850293C (en) 2019-10-08
BR112014012491A2 (en) 2017-06-06
JP2015500229A (en) 2015-01-05
MY184076A (en) 2021-03-17

Similar Documents

Publication Publication Date Title
ZA201403557B (en) Hpv chimaeric particle
AP4082A (en) Anti-cd40 antibodies
GB2518765B (en) Particle separator
ZA201305323B (en) Cea antibodies
GB201103955D0 (en) Antibodies
GB201109319D0 (en) Fine particles
SG11201400236YA (en) Viral clearance methods
EP2699670A4 (en) Cell-synthesized particles
EP2755020A4 (en) Particle detector
PL2380962T3 (en) Particle
EP2867303A4 (en) Silsesquioxane-like particles
IL229106A (en) Encapsulated particle
PL2584028T3 (en) Particle
EP2714074A4 (en) Anti-emr1 antibodies
GB2491820B (en) Clipboard
GB201100668D0 (en) Particle splitting
AU2011903847A0 (en) Functional Particles
AU2012902635A0 (en) Thirsty Pooch
AU2012904111A0 (en) Functional Particles
GB201013716D0 (en) Particle dispenser
GB201102529D0 (en) Fine B-Day
GB201110793D0 (en) Easy carry
GB201107519D0 (en) Sealed assembly
GB201117947D0 (en) Wheelbarrows
GB201109957D0 (en) Electromagnetic virology